In the current study, we investigated whether Staphylococcus aureus grown from affected skin of atopic dermatitis (AD) patients secreted identifiable toxins that could act as allergens to induce IgE-mediated basophil histamine release. The secreted toxins of S. aureus grown from AD patients were identified by ELISA using antibodies specific for staphylococcal enterotoxin (SE) exfoliative toxin (ET), or toxic shock syndrome toxin (TSST-1). S. aureus isolates from 24 of 42 AD patients secreted identifiable toxins with SEA, SEB, and TSST accounting for 92% of the isolates. 32 of 56 AD sera (57%) tested contained significant levels of IgE primarily to SEA, SEB, and/or TSST. In contrast, although SEA, SEB, or TSST secreting S. aureus could be recovered from the skin of psoriasis patients, their sera did not contain IgE antitoxins. Freshly isolated basophils from 10 AD patients released 5-59% of total histamine in response to SEA, SEB, or TSST-1 but only with toxins to which patients had specific IgE. Basophils from eight other AD patients and six normal controls who had no IgE antitoxin failed to demonstrate toxin-induced basophil histamine release. Stripped basophils sensitized with three AD sera containing IgE to toxin released 15-41% of total basophil histamine only when exposed to the relevant toxin, but not to other toxins. Sensitization of basophils with AD sera lacking IgE antitoxin did not result in release of histamine to any of the toxins tested. These data indicate that a subset of patients with AD mount an IgE response to SEs that can be grown from their skin. These toxins may exacerbate AD by activating mast cells, basophils, and/or other Fc epsilon-receptor bearing cells armed with the relevant IgE antitoxin.
D Y Leung, R Harbeck, P Bina, R F Reiser, E Yang, D A Norris, J M Hanifin, H A Sampson
Title and authors | Publication | Year |
---|---|---|
Clinical role for a superantigen in Yersinia pseudotuberculosis infection
J Abe, M Onimaru, S Matsumoto, S Noma, K Baba, Y Ito, T Kohsaka, T Takeda |
Journal of Clinical Investigation | 1997 |
Immunologic Basis of Chronic Allergic Diseases: Clinical Messages from the Laboratory Bench
DY Leung |
Pediatric Research | 1997 |
Nonspecific T-cell homing during inflammation in atopic dermatitis: Expression of cutaneous lymphocyte-associated antigen and integrin αEβ7 on skin-infiltrating T cells
IJ de Vries, EG Langeveld-Wildschut, FC van Reijsen, IC Bihari, CA Bruijnzeel-Koomen, T Thepen |
Journal of Allergy and Clinical Immunology | 1997 |
Mast cells in infection and immunity
SN Abraham, R Malaviya |
Infection and immunity | 1997 |
Pathogenesis and management of wound infections in domestic animals
WC Noble, DH Lloyd |
Veterinary Dermatology | 1997 |
Reduction of Staphylococcus aureus in atopic skin lesions with acid electrolytic water - a new therapeutic strategy for atopic dermatitis
M Sasai-Takedatsu, T Kojima, A Yamamoto, K Hattori, S Yoshijima, S Taniuchi, S Namura, H Akamatsu, T Horio, Y Kobayashi |
Allergy | 1997 |
IgG-Binding Components of Staphylococcal Enterotoxins in Patients with Atopic Dermatitis
D Nissen, LJ Pedersen, PS Skov, GL Vejlsgaard, LK Poulsen, JO Jarløv, T Karlsmark, H Nolte |
Annals of Allergy Asthma & Immunology | 1997 |
Immunothérapie spécifique de la dermatite atopique
JM Saint-Remy |
Revue Française d'Allergologie et d'Immunologie Clinique | 1997 |
Psoriasis and eczema
ME McMenamin, EC Sweeney |
Current Diagnostic Pathology | 1997 |
New Trends in Allergy IV
J Ring, H Behrendt, D Vieluf |
1997 | |
Association of Erythrodermic Cutaneous T-Cell Lymphoma, Superantigen-Positive Staphylococcus aureus, and Oligoclonal T-Cell Receptor Vβ Gene Expansion
CM Jackow, JC Cather, V Hearne, AT Asano, JM Musser, M Duvic |
Blood | 1997 |